Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 26, 2013
Grant Date -
Sep 2, 2010
app pub date -
Oct 13, 2009
filing date -
Sep 30, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to novel synthetic derivatives of β-glycolipids and uses thereof as immunomodulators. More particularly, the invention relates to synthetic derivatives of β-glycolipids, specifically, the compounds of any one of Formula I, II III and IV or any mixture or combination thereof, and particularly the ALIB-97 (Formula II) derivative and uses thereof for the treatment of different pathologic disorders, particularly, immune-related hepatic disorders and pathologies associated with the metabolic syndrome.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully